|
Crowell, R E; Hallin, G; Heaphy, E et al. (1995) Hyperoxic suppression of Fc-gamma receptor-mediated phagocytosis by isolated murine pulmonary macrophages. Am J Respir Cell Mol Biol 12:190-5
|
|
Reilly, B D; Makrides, S C; Ford, P J et al. (1994) Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J Biol Chem 269:7696-701
|
|
Wang, R H; Phillips Jr, G; Medof, M E et al. (1993) Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 92:1326-35
|
|
Hicks, P S; Saunero-Nava, L; Du Clos, T W et al. (1992) Serum amyloid P component binds to histones and activates the classical complement pathway. J Immunol 149:3689-94
|
|
Crowell, R E; Du Clos, T W; Montoya, G et al. (1991) C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI. J Immunol 147:3445-51
|
|
Mold, C; Walter, E I; Medof, M E (1990) The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor. J Immunol 145:3836-41
|
|
Mold, C (1989) Effect of membrane phospholipids on activation of the alternative complement pathway. J Immunol 143:1663-8
|
|
Mold, C; Bradt, B M; Nemerow, G R et al. (1988) Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med 168:949-69
|
|
Michalek, M T; Bremer, E G; Mold, C (1988) Effect of gangliosides on activation of the alternative pathway of human complement. J Immunol 140:1581-7
|
|
Michalek, M T; Mold, C; Bremer, E G (1988) Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J Immunol 140:1588-94
|
Showing the most recent 10 out of 12 publications
